Clinical trial
Effects of 5-Aminolevulinic Acid on Glucose Metabolism
NCT01610778
Study timeline
Study start (unknown)2012-05-01Date precision: month
Registry last updated2013-12-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes on Medicationunresolved
Interventions
PlaceboDIETARY_SUPPLEMENT
5-aminolevulinic acid phosphateDIETARY_SUPPLEMENT
Sponsors & collaborators
Hiroshima Universitylead sponsor
SBI Pharmaceuticals Co, Ltd.collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01610778 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.